TIAZAC EXTENDED RELEASE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0187-2615 -
Package NDC
0187-2615-30 -
Package NDC
0187-2615-90 -
Application number
NDA020401 -
SPL ID
d16e7ace-3d95-4196-a7b0-cdd26f3bd8e7 -
SPL set ID
c567fe7e-887e-4291-a0d1-2dd3f25cbf25 -
UNII
OLH94387TE -
RxCUI
830795 -
RxCUI
830801 -
RxCUI
830837 -
RxCUI
830845 -
RxCUI
830861 -
RxCUI
831193 -
RxCUI
831244 -
RxCUI
831296 -
RxCUI
831323 -
RxCUI
831347 -
RxCUI
831359 -
RxCUI
831360
What the source publishes
- Labeler
- Bausch Health US, LLC
- Active ingredients
- diltiazem hydrochloride
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TIAZAC EXTENDED RELEASE",
"splId": "d16e7ace-3d95-4196-a7b0-cdd26f3bd8e7",
"labels": [
{
"setId": "c567fe7e-887e-4291-a0d1-2dd3f25cbf25",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c567fe7e-887e-4291-a0d1-2dd3f25cbf25",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c567fe7e-887e-4291-a0d1-2dd3f25cbf25"
}
],
"routes": [
"ORAL"
],
"labeler": "Bausch Health US, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0187-2615-30)",
"package_ndc": "0187-2615-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20140820"
},
{
"sample": false,
"description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0187-2615-90)",
"package_ndc": "0187-2615-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20140820"
}
],
"productId": "0187-2615_d16e7ace-3d95-4196-a7b0-cdd26f3bd8e7",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "0187-2615",
"deaSchedule": null,
"genericName": "diltiazem hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DILTIAZEM HYDROCHLORIDE",
"strength": "300 mg/1"
}
],
"applicationNumber": "NDA020401",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140820",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"OLH94387TE"
],
"rxcui": [
"830795",
"830801",
"830837",
"830845",
"830861",
"831193",
"831244",
"831296",
"831323",
"831347",
"831359",
"831360"
],
"spl_set_id": [
"c567fe7e-887e-4291-a0d1-2dd3f25cbf25"
],
"manufacturer_name": [
"Bausch Health US, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0187-2615_d16e7ace-3d95-4196-a7b0-cdd26f3bd8e7"